Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Combined With Nalbuphine for Quality of Recovery After General Anesthesia in Elderly Patients
NCT05769530Phase 4Completed
- Start
- May 2023
- Primary completion
- May 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial in Emergence agitation (EA) comparing placebo group, DEX and Nalbuphine group and nalbuphine group (3 arms). Primary endpoint: Occurrence of Emergence Agitation at 30 months. Started May 2023; status: completed.
02
Drugs
nalbuphinedexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT05769530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05769530.